eFFECTOR Therapeutics (EFTR)
OTHER OTC:EFTR

eFFECTOR Therapeutics (EFTR) Cash flow

261 Followers

eFFECTOR Therapeutics Cash Flow

EFTR's free cash flow for Q1 2024 was $-7.28M. For the 2024 fiscal year, EFTR's free cash flow was decreased by $-3.75M and operating cash flow was $-7.28M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -31.26M$ -29.55M$ -25.90M$ -24.89M$ 13.84M
Investing Cash Flow
$ -783.00K$ 14.48M$ -17.86M$ 565.00K$ -154.00K
Financing Cash Flow
$ 29.36M$ 21.23M$ 2.77M$ 58.81M$ -1.89M
Cash Flow From Discontinued Operation
-----
Other Cash Adjustment Inside Changein Cash
-----
End Cash Position
$ 30.71M$ 14.88M$ 8.71M$ 49.71M$ 15.22M
Income Tax Paid Supplemental Data
-----
Interest Paid Supplemental Data
$ 2.53M$ 2.53M$ 1.82M$ 1.34M$ 975.00K
Issuance Of Capital Stock
$ 15.39M$ 6.71M$ 2.80M$ 56.00K-
Issuance Of Debt
$ -556.00K-$ -37.00K$ 19.84M$ 0.00
Repayment Of Debt
$ -556.00K-$ -37.00K-$ -2.00M
Free Cash Flow
$ -22.71M$ -29.65M$ -25.90M$ -24.89M$ 13.68M
Domestic Sales
-----
Foreign Sales
-----
Currency in USD

eFFECTOR Therapeutics Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis